Levy Emile, Fallet-Bianco Catherine, Auclair Nickolas, Patey Natalie, Marcil Valérie, Sané Alain Théophile, Spahis Schohraya
Azrieli Research Center, CHU Ste-Justine and Department of Nutrition, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Azrieli Research Center, CHU Ste-Justine and Pathology & Cell Biology, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Biomedicines. 2024 Jul 12;12(7):1548. doi: 10.3390/biomedicines12071548.
Over the past three decades, significant efforts have been focused on unraveling congenital intestinal disorders that disrupt the absorption of dietary lipids and fat-soluble vitamins. The primary goal has been to gain deeper insights into intra-enterocyte sites, molecular steps, and crucial proteins/regulatory pathways involved, while simultaneously identifying novel therapeutic targets and diagnostic tools. This research not only delves into specific and rare malabsorptive conditions, such as chylomicron retention disease (CRD), but also contributes to our understanding of normal physiology through the utilization of cutting-edge cellular and animal models alongside advanced research methodologies. This review elucidates how modern techniques have facilitated the decoding of CRD gene defects, the identification of dysfunctional cellular processes, disease regulatory mechanisms, and the essential role of coat protein complex II-coated vesicles and cargo receptors in chylomicron trafficking and endoplasmic reticulum (ER) exit sites. Moreover, experimental approaches have shed light on the multifaceted functions of SAR1B GTPase, wherein loss-of-function mutations not only predispose individuals to CRD but also exacerbate oxidative stress, inflammation, and ER stress, potentially contributing to clinical complications associated with CRD. In addition to dissecting the primary disease pathology, genetically modified animal models have emerged as invaluable assets in exploring various ancillary aspects, including responses to environmental challenges such as dietary alterations, gender-specific disparities in disease onset and progression, and embryonic lethality or developmental abnormalities. In summary, this comprehensive review provides an in-depth and contemporary analysis of CRD, offering a meticulous examination of the CRD current landscape by synthesizing the latest research findings and advancements in the field.
在过去三十年中,大量工作集中在揭示扰乱膳食脂质和脂溶性维生素吸收的先天性肠道疾病。主要目标是更深入地了解肠细胞内的位点、分子步骤以及涉及的关键蛋白质/调节途径,同时识别新的治疗靶点和诊断工具。这项研究不仅深入探讨了特定的罕见吸收不良病症,如乳糜微粒滞留病(CRD),还通过利用前沿的细胞和动物模型以及先进的研究方法,增进了我们对正常生理学的理解。本综述阐明了现代技术如何促进对CRD基因缺陷的解码、功能失调的细胞过程的识别、疾病调节机制以及衣被蛋白复合物II包被囊泡和货物受体在乳糜微粒运输和内质网(ER)出口位点中的重要作用。此外,实验方法揭示了SAR1B GTPase的多方面功能,其中功能丧失突变不仅使个体易患CRD,还会加剧氧化应激、炎症和内质网应激,可能导致与CRD相关的临床并发症。除了解析主要疾病病理外,基因改造动物模型已成为探索各种辅助方面的宝贵资产,包括对饮食改变等环境挑战的反应、疾病发病和进展中的性别差异以及胚胎致死率或发育异常。总之,这篇全面的综述对CRD进行了深入和当代的分析,通过综合该领域的最新研究成果和进展,对CRD的当前状况进行了细致的审视。